WINNERGY MEDICAL |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.87 THB | -1.58% |
|
-1.58% | -36.82% |
| Sales 2022 | 703M 19.22M | Sales 2023 | 639M 17.47M | Capitalization | 1.18B 32.36M |
|---|---|---|---|---|---|
| Net income 2022 | 60M 1.64M | Net income 2023 | 30M 820K | EV / Sales 2022 | 2.56 x |
| Net Debt 2022 | 99.56M 2.72M | Net Debt 2023 | 221M 6.05M | EV / Sales 2023 | 2.2 x |
| P/E ratio 2022 |
28.1
x | P/E ratio 2023 |
38.6
x | Employees | - |
| Yield 2022 |
1.34% | Yield 2023 |
1% | Free-Float | 24.31% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.58% | ||
| 1 week | -1.58% | ||
| Current month | -1.58% | ||
| 1 month | -22.08% | ||
| 3 months | -35.52% | ||
| 6 months | -38.49% | ||
| Current year | -36.82% |
1 week
1.86
1.94
1 month
1.852.40
Current year
1.853.18
1 year
1.853.98
3 years
1.858.30
5 years
1.858.30
10 years
1.858.30
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 56 | 03-12-31 | |
| Director of Finance/CFO | - | 20-05-31 | |
| Chief Operating Officer | 55 | 19-07-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 56 | 03-12-31 | |
| Director/Board Member | 45 | 23-03-07 | |
| Director/Board Member | 36 | 23-05-11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-03 | 1.87 | -1.58% | 12,400 |
| 24-07-02 | 1.9 | -1.55% | 105,030 |
| 24-07-01 | 1.93 | +1.58% | 39,101 |
| 24-06-28 | 1.9 | -1.55% | 64,100 |
| 24-06-27 | 1.93 | +1.58% | 180,065 |
End-of-day quote Thailand S.E., July 02, 2024
More quotes
Winnergy Medical Public Company Limited is a Thailand-based company, which is engaged in the distribution of medical and diagnostics equipment. The Company imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The Company operates through two segments: Medical products and Other products. The Company's businesses include Trading business and Laboratory services. Its Trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The Company imports cytology and molecular microbiology products from Hologic Co., Ltd. from the United States. The Company imports products related to blood donation from Haemonetics Company of the United States. It distributes blood diagnostics products from Grifols, Spain. The Company also distributes clinical products, including reagents, such as Clinical cell separation, In vitro diagnostic (IVD) and Analyte specific reagents (ASR).
Calendar
2024-08-11
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -36.82% | 20.42M | |
| -7.03% | 178B | |
| -6.32% | 98.95B | |
| -6.15% | 66.14B | |
| -10.62% | 44.11B | |
| +8.34% | 43.82B | |
| +11.91% | 42.07B | |
| +11.64% | 28.92B | |
| +17.68% | 24.69B | |
| -8.87% | 23.38B |
- Stock Market
- Equities
- WINMED Stock
